-
Citizens JMP Reiterates Market Perform Rating on Generation Bio (GBIO)
-
Wedbush Downgrades Generation Bio (GBIO) to Neutral, Maintains $7 PT on Anticipated Cash Position in 1 Year
-
Generation Bio (GBIO) PT Lowered to $12 at Jefferies
-
Generation Bio delivers siRNA to T cells in primate study
-
Generation Bio Co. (GBIO) Tops Q1 EPS by 8c
-
Citizens JMP Reiterates Market Perform Rating on Generation Bio (GBIO)
-
Generation Bio Co. (GBIO) Misses Q4 EPS by 2c
-
Generation Bio Co. (GBIO) Tops Q3 EPS by 4c

